Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study

• Khaled M. Musallam,
• Maria Domenica Cappellini,
• Shahina Daar,
• Mehran Karimi,
• Amal El-Beshlawy,
• Giovanna Graziadei,
• Matthew Magestro,
• Jerome Wulff,
• Guilhem Pietri,
• Ali T. Taher

Affiliations

Khaled M. Musallam

University of Milan, Ca Granda Foundation IRCCS, Ospedale Maggiore Policlinico, Milan, Italy;American University of Beirut Medical Center, Lebanon

Maria Domenica Cappellini

University of Milan, Ca Granda Foundation IRCCS, Ospedale Maggiore Policlinico, Milan, Italy

Shahina Daar

Sultan Qaboos University, Muscat, Oman

Mehran Karimi

Hematology Research Center, Shiraz University of Medical Sciences, Iran

Amal El-Beshlawy

Cairo University, Egypt

Giovanna Graziadei

University of Milan, Ca Granda Foundation IRCCS, Ospedale Maggiore Policlinico, Milan, Italy

Matthew Magestro

Novartis Pharmaceuticals Corporation, NJ, USA

Jerome Wulff

HERON Evidence Development Ltd., London, UK

Guilhem Pietri

HERON Evidence Development Ltd., London, UK

Ali T. Taher

American University of Beirut Medical Center, Lebanon;Chronic Care Center, Hazmieh, Lebanon